From Pravachol to protocol
Bristol-Myers Squibb Chairman & CEO Charles Heimbold is the Bush Administration nominee for ambassador to Sweden. Heimbold is retiring from Bristol this year (1"The Pink Sheet" Feb. 12, p. 25)
You may also be interested in...
Bristol-Myers Squibb is committed to active deal-making during the start of the Dolan period.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials